Page last updated: 2024-10-27

gabexate and Ischemic Attack, Transient

gabexate has been researched along with Ischemic Attack, Transient in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, M1
Yanamoto, H1
Kikuchi, H1
Okamoto, S1

Other Studies

2 other studies available for gabexate and Ischemic Attack, Transient

ArticleYear
[Experimental vasospasms--significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine (author's transl)].
    Neurologia medico-chirurgica, 1980, Volume: 20, Issue:3

    Topics: Animals; Diphenhydramine; Dogs; Fibrin Fibrinogen Degradation Products; Gabexate; Guanidines; Haptog

1980
Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
    Surgical neurology, 1994, Volume: 42, Issue:5

    Topics: Animals; Benzamidines; Betamethasone; Cyclosporine; Drug Administration Schedule; Gabexate; Guanidin

1994